SY-002
N/A
Report date: 2026/04/28 20:00:22
NME
Base Information
Drug NameSY-002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSynrx Therapeutics (Hangzhou) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSynrx Therapeutics (Hangzhou) Co LtdBeijing Jiacheng Biomedical Technology Development Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A